Scientists say they have developed a new type of antibiotic to treat bacteria that is resistant to most current antibiotics and kills a large percentage of people with an invasive infection. The ...

Healthy people can also carry the Acinetobacter bacteria on their skin, particularly if they work in a healthcare setting. It can survive for a long time on dry surfaces, making it difficult to ...

Acinetobacter bacteria are not airborne, but can be spread through direct contact with surfaces, objects, or the skin of people that are contaminated with A. baumannii. Bloodstream infections often ...

In an effort to illustrate that genomic surveillance can build the foundation for scaleable precision phage therapy, an international collaboration analyzed the genomes of over 15,000 cases of ...

A research team led by Beate Averhoff and Volker Müller of Goethe University Frankfurt has discovered a fundamental mechanism that helps the dreaded hospital pathogen Acinetobacter baumannii to ...

Acinetobacter baumannii are bacteria that cause infections in the blood, lungs, kidneys, brain, and other organs. These bacteria are nonmotile (don't move on their own), strictly aerobic (need oxygen ...

The pathogen Acinetobacter baumannii can survive on hospital surfaces -- without water -- for months, an ability that has helped it become a leading cause of hospital-acquired infections. Now, a team ...

Scientists have used artificial intelligence to identify a new antibiotic that might be useful to fight a deadly drug-resistant bacteria commonly found in hospitals and medical offices. Researchers ...

Researchers discovered an unexpected link between zinc deficiency, the pro-inflammatory cytokine interleukin-13 (IL-13), and Acinetobacter baumannii lung infection and demonstrated that blocking IL-13 ...

XACDURO is a new FDA-approved treatment used to fight against HABP/VABP infections caused by isolates of Acinetobacter baumannii-calcoaceticus complex, which can include those resistant to carbapenems ...

University of Liverpool researchers have engineered a library of strains that can be used to develop new antibacterial compounds to help address antimicrobial resistance (AMR) in Acinetobacter ...